Evidence map›Paper›PMID 40004106›Full record

ArticleInternational journal of molecular sciences2025

Integrated Analysis of Somatic DNA Variants and DNA Methylation of Tumor Suppressor Genes in Colorectal Cancer.

Hisashi Nishiki, Hiroki Ura, Sumihito Togi, Hisayo Hatanaka, Hideto Fujita, Hiroyuki Takamura, Yo Niida

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hisashi NishikiGeneral and Digestive Surgery, Kanazawa Medical University, Uchinada 920-0293, Japan.
Hiroki UraCenter for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada 920-0293, Japan.ORCID 0000-0002-7600-3481
Sumihito TogiCenter for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada 920-0293, Japan.ORCID 0000-0002-3189-8111
Hisayo HatanakaCenter for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada 920-0293, Japan.
Hideto FujitaGeneral and Digestive Surgery, Kanazawa Medical University, Uchinada 920-0293, Japan.ORCID 0000-0002-6702-8011
Hiroyuki TakamuraGeneral and Digestive Surgery, Kanazawa Medical University, Uchinada 920-0293, Japan.
Yo NiidaCenter for Clinical Genomics, Kanazawa Medical University Hospital, Uchinada 920-0293, Japan.ORCID 0000-0001-5641-7962

Funding

Kanazawa Medical University 11181Kanazawa Medical University 26699
6 · The paper itself

Abstract

DNA methylation of tumor suppressor genes in cancer is known to be a mechanism for silencing gene expression, but much remains unknown about its extent and relationship to somatic variants at the DNA sequence level. In this study, we comprehensively analyzed DNA methylation and somatic variants of all gene regions across the genome of the major tumor suppressor genes,

Indexed as

Colorectal NeoplasmsDNA MethylationGenes, Tumor SuppressorAdenomatous Polyposis Coli ProteinFemaleGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingHumansMaleMutL Protein Homolog 1Smad4 ProteinTumor Suppressor Protein p53Adenomatous Polyposis Coli ProteinMutL Protein Homolog 1Smad4 ProteinTumor Suppressor Protein p53colorectal cancerDNA methylationloss of heterozygosity (LOH)next-generation sequencing (NGS)somatic varianttumor suppressor gene

Identifiers

PMID40004106
PMCPMC11855003

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.